UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Takeda Korea labor union to ask Japanese headquarters about restructuring
Takeda Pharmaceutical Korea’s trade union, in dispute with management durin...
by Kim Yun-mi
|
2019-09-19 14:11
라인
Chong Kun Dang releases trial result for diabetes treatment
Chong Kun Dang said that it has presented a clinical trial result, which it...
by Lee Han-soo
|
2019-09-19 14:11
라인
Indian biosimilar of rituximab to undergo test in Korea
India’s largest generics drugmaker Dr. Reddy's Laboratories said it wou...
by Lee Hye-seon
|
2019-09-19 10:31
라인
Ono Pharma, BMS unveil two P3 trial analyses for Opdivo
Ono Pharmaceutical and Bristol-Myers Squibb have presented pooled data on t...
by Lee Han-soo
|
2019-09-18 15:48
라인
CJ Healthcare to export gastroesophageal reflux treatment to Indonesia
CJ Healthcare said that it plans to export K-CAB (Ingredient: tegoprazan), ...
by Lee Han-soo
|
2019-09-18 11:37
라인
Will Tagrisso study results affect use of EGFR TKIs in lung cancer?
AstraZeneca’s imminent announcement of overall survival (OS) data of Tagris...
by Kim Yun-mi
|
2019-09-18 11:36
라인
Hanmi spurs new immunotherapy development through open innovation
Hanmi Pharmaceutical said it is launching new development projects in the f...
by Lee Han-soo
|
2019-09-17 18:14
라인
‘Lundbeck to work with parliament to prevent suicide in Korea’
Lundbeck, which sells anti-depressants Lexapro and Brintellix, dementia tre...
by Kim Yun-mi
|
2019-09-17 15:19
라인
Shinpoong's malaria treatment expands global presence
Shinpoong Pharmaceutical said that Pyramax, its malaria treatment, is quick...
by Lee Han-soo
|
2019-09-17 15:13
라인
SK Bioscience to export influenza vaccine to Asian countries
SK Bioscience will export 250,000 doses of Skycellflu, the first cell-cultu...
by Lee Han-soo
|
2019-09-17 11:27
라인
Lenvima to get benefit as 1st-line treatment of hepatocellular carcinoma
Lenvima (ingredient: lenvatinib), a new liver cancer drug that arrived in a...
by Kim Yun-mi
|
2019-09-16 16:20
라인
'Roche Korea to put patient accessibility first'
Roche Korea, the number one company in the domestic anticancer market, is l...
by Lee Han-soo
|
2019-09-16 15:41
라인
GC’s Hunter syndrome drug to get priority screening in China
GC said that China’s National Medical Products Administration (NMPA) has de...
by Lee Han-soo
|
2019-09-16 13:56
라인
GSK’s chronic hand eczema treatment faces local competition
GSK Korea is facing competition from DongKoo Bio&Pharma for its exclusive c...
by Lee Han-soo
|
2019-09-12 07:22
라인
Chong Kun Dang wins patent suit against Novartis over immunosuppressant
Chong Kun Dang said it has won the lawsuit against Novartis over the patent...
by Jeong Sae-im
|
2019-09-11 15:16
라인
AstraZeneca to challenge Roche in small-cell lung cancer treatment market
AstraZeneca’s Imfinzi (ingredient: durvalumab) has sharpened up its weapon ...
by Kim Yun-mi
|
2019-09-11 14:18
라인
Amgen fetes 1st anniversary of getting expanded indication for Repatha
Amgen Korea said that its cardio-vascular disease business unit has held an...
by Lee Han-soo
|
2019-09-11 13:56
라인
Hanmi to launch 3-substance combination in Latin America
Hanmi Pharmaceutical said that it has become the first local corporation to...
by Lee Han-soo
|
2019-09-11 13:56
라인
Daewoong to test botulinum toxin Nabota for hair loss
Daewoong Pharmaceutical said it would conduct a clinical trial on botulinum...
by Jeong Sae-im
|
2019-09-11 13:56
라인
Novartis withdraws suit against Ahngook’s generic drug
Novartis canceled its lawsuit against Ahngook Pharmaceutical’s anti-diabeti...
by Jeong Sae-im
|
2019-09-10 15:38
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top